Mucormycosis in COVID-19 (MUNCO)

Montefiore Medicine Academic Health System

Status: Completed

Conditions: Candida Infection; Aspergillosis; Covid19; Mucormycosis

Study type: Observational

Funder types: Other

Identifiers

NCT04935463

2021-13086

Details and patient eligibility

About

The purpose is to allow phsyician reporters to contribute to MUNCO registry. Mucormycosis in COVID-19 is a rapidly escalating medical emergency reported in high numbers in India during the ongoing coronavirus surge. There is very little known about the risk factors, patterns and complications of mucormycosis as it occurs either during the infection or treatment phase of the novel coronavirus (COVID-19). In light of this emerging epidemic within a pandemic, it is of time sensitive importance to obtain a better understanding of the risk factors and outcomes of this fatal complication

Enrollment: 728 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Diagnosed case of Mycotic Infection in COVID-19

Exclusion criteria

• None